State Street SPDR S&P Bio... (XBI)

NYSEArca: XBI · Echtzeitkurs · USD

168.44

-0.66 (-0.39%)

Zum Schluss: Aug 26, 2026, 6:40 PM

Kurs, die wichtigsten Kennzahlen und die neuesten Nachrichten an einem Ort.

-0.39% (1D)

Keine Daten verfügbar

Geld	168.97
Marktkapitalisierung	n/a
Umsatz (TTM)	n/a
Nettogewinn (TTM)	n/a
	n/a
	n/a
	n/a
	n/a
KBV (TTM)	n/a
KUV (TTM)	n/a
Termin Quartalszahlen	n/a

Brief	168.97
Volumen	7,185,518
Ø Vol. (20D)	9,051,342
Eröffnung	168.08
Vortagesschluss	169.10
Tagesspanne	166.51 - 169.04
52-Wk Range	89.33 - 169.89
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über XBI

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI")....

[Mehr lesen]

Branche n/a

Sektor n/a

IPO Datum Feb 6, 2006

Mitarbeiter n/a

Börse NYSEArca

Tickersymbol XBI

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr undefined betrug der Umsatz von State Street SPDR S&P Biotech ETF n/a, ein Anstieg von undefined% im Vergleich zum Vorjahr (n/a). Der Gewinn lag bei n/a, ein Anstieg von undefined %.

Finanzberichte

Nachrichten

vor 4 Tagen · GuruFocus.com

BofA Sees a Stock Market Setup Starting to Change

Several hated assets could benefit if consensus starts cracking

vor 4 Tagen · MarketWatch

The Treasury, the Fed and the threat to your money

Also in Weekend Reads: The Gen Z online sports-betting trend, what’s next for Apple as Tim Cook exits, and a bullish take on Nvidia heading into earnings.

vor 5 Tagen · etf.com

Moderna's 177% Surge Powers a Broad Biotech Rally

<p>Moderna's 177% pop on a Phase 3 cancer-vaccine win rippled far beyond one stock.</p>

vor 5 Tagen · Barrons.com

3 Moves to Protect You From a 60/40 Nightmare

A bond market selloff has pressured 60/40 investment portfolios, which have returned 8% on average this year compared with 13% for the S&P 500. Investors can look to healthcare stocks for relief.

vor 5 Tagen · Barrons.com

Moderna Is Up 350% Since Our Recommendation. Here’s What to Do Next.

Moderna’s breakthrough highlights a broader transformation, as AI accelerates the clinical development of therapies at a pace that would have seemed unimaginable a few years ago.

Seite 1 von 2

State Street SPDR S&P Bio... (XBI)

Über XBI

Finanzielle Entwicklung

Gewinnüberraschung

Warum der Kurs sich bewegte